CD34(+) cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis.
Nakamura T, Torimura T, Iwamoto H, Kurogi J, Inoue H, Hori Y, Sumie S, Fukushima N, Sakata M, Koga H, Abe M, Ikezono Y, Hashimoto O, Ueno T, Oho K, Okamura T, Okuda S, Kawamoto A, Ii M, Asahara T, Sata M.
Nakamura T, et al. Among authors: sumie s.
J Gastroenterol Hepatol. 2014 Oct;29(10):1830-8. doi: 10.1111/jgh.12622.
J Gastroenterol Hepatol. 2014.
PMID: 24731186